Caladrius Biosciences (CLBS) Reports Q4 Loss of $0.73/Share

Caladrius Biosciences (NASDAQ: CLBS) reported Q4 EPS of ($0.73), versus ($5.92) reported last year. Revenue for the quarter came in at $10.18 million, versus $7.56 million reported last year.

For earnings history and earnings-related data on Caladrius Biosciences (CLBS) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Phillip Securities Reiterates Buy Rating on Sea Ltd. (SE)
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49